Do analysts prefer ICG or EBON?

Intchains Group presently has a consensus price target of $2.50, suggesting a potential upside of 158.83%. Given Intchains Group's stronger consensus rating and higher possible upside, equities analysts plainly believe Intchains Group is more favorable than Ebang International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Intchains Group 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Ebang International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings & valuation, ICG or EBON?

Intchains Group has higher revenue and earnings than Ebang International. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Intchains Group $31.58M 1.86 -$6.80M -$0.12 N/A Ebang International $6.54M 2.19 -$14.09M N/A N/A

Do analysts recommend EBON or TACT?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ebang International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 TransAct Technologies 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has stronger earnings & valuation, EBON or TACT?

TransAct Technologies has higher revenue and earnings than Ebang International. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ebang International $6.54M 2.19 -$14.09M N/A N/A TransAct Technologies $51.48M 1.02 -$1.24M -$0.04 N/A

Do analysts recommend VTIX or EBON?

Virtuix presently has a consensus target price of $11.00, suggesting a potential upside of 752.71%. Given Virtuix's stronger consensus rating and higher probable upside, equities research analysts clearly believe Virtuix is more favorable than Ebang International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Virtuix 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Ebang International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings & valuation, VTIX or EBON?

Ebang International has higher revenue and earnings than Virtuix. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Virtuix $4.25M 9.10 -$16.80M -$0.70 N/A Ebang International $6.54M 2.19 -$14.09M N/A N/A

Is VTIX or EBON more profitable?

Company Net Margins Return on Equity Return on Assets Virtuix N/A N/A N/A Ebang International N/A N/A N/A

Do analysts rate EBON or FOXX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ebang International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Foxx Development 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings and valuation, EBON or FOXX?

Foxx Development has higher revenue and earnings than Ebang International. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ebang International $6.54M 2.19 -$14.09M N/A N/A Foxx Development $65.92M 0.29 -$9.02M -$6.87 N/A

Is EBON or FOXX more profitable?

Ebang International has a net margin of 0.00% compared to Foxx Development's net margin of -79.80%. Company Net Margins Return on Equity Return on Assets Ebang International N/A N/A N/A Foxx Development -79.80% N/A -59.35%

Do analysts rate EBON or QCLS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ebang International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Mymd Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation and earnings, EBON or QCLS?

Mymd Pharmaceuticals has lower revenue, but higher earnings than Ebang International. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ebang International $6.54M 2.19 -$14.09M N/A N/A Mymd Pharmaceuticals N/A N/A -$11.63M -$3.48 N/A

Is EBON or QCLS more profitable?

Ebang International's return on equity of 0.00% beat Mymd Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Ebang International N/A N/A N/A Mymd Pharmaceuticals N/A -91.64% -47.48%

Does the media prefer EBON or QCLS?

In the previous week, Ebang International's average media sentiment score of 1.89 equaled Mymd Pharmaceuticals'average media sentiment score. Company Overall Sentiment Ebang International Very Positive Mymd Pharmaceuticals Very Positive

Ebang International (EBON) Competitors

$2.19 +0.03 (+1.39%)

As of 02:09 PM Eastern

Compare

EBON vs. ICG, TACT, VTIX, FOXX, and QCLS

Should you buy Ebang International stock or one of its competitors? Ebang International's main competitors and comparable companies include Intchains Group (ICG), TransAct Technologies (TACT), Virtuix (VTIX), Foxx Development (FOXX), and Mymd Pharmaceuticals (QCLS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "technology hardware, storage & peripherals" industry.

How does Ebang International compare to Intchains Group?

Intchains Group (NASDAQ:ICG) and Ebang International (NASDAQ:EBON) are both small-cap technology companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, valuation, profitability, analyst recommendations, earnings and dividends.

Intchains Group presently has a consensus price target of $2.50, suggesting a potential upside of 158.83%. Given Intchains Group's stronger consensus rating and higher possible upside, equities analysts plainly believe Intchains Group is more favorable than Ebang International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intchains Group	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Ebang International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

1.2% of Ebang International shares are owned by institutional investors. 25.4% of Ebang International shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Ebang International has a net margin of 0.00% compared to Intchains Group's net margin of -24.68%. Ebang International's return on equity of 0.00% beat Intchains Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intchains Group	-24.68%	-5.29%	-5.08%
Ebang International	N/A	N/A	N/A

Intchains Group has a beta of 1.1, suggesting that its share price is 10% more volatile than the broader market. Comparatively, Ebang International has a beta of 2.99, suggesting that its share price is 199% more volatile than the broader market.

In the previous week, Intchains Group had 1 more articles in the media than Ebang International. MarketBeat recorded 1 mentions for Intchains Group and 0 mentions for Ebang International. Ebang International's average media sentiment score of 1.89 beat Intchains Group's score of 1.20 indicating that Ebang International is being referred to more favorably in the news media.

Company	Overall Sentiment
Intchains Group	Positive
Ebang International	Very Positive

Intchains Group has higher revenue and earnings than Ebang International.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intchains Group	$31.58M	1.86	-$6.80M	-$0.12	N/A
Ebang International	$6.54M	2.19	-$14.09M	N/A	N/A

Summary

Ebang International beats Intchains Group on 8 of the 14 factors compared between the two stocks.

How does Ebang International compare to TransAct Technologies?

Ebang International (NASDAQ:EBON) and TransAct Technologies (NASDAQ:TACT) are both small-cap technology companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, profitability, institutional ownership, dividends and valuation.

Ebang International has a net margin of 0.00% compared to TransAct Technologies' net margin of -0.75%. Ebang International's return on equity of 0.00% beat TransAct Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ebang International	N/A	N/A	N/A
TransAct Technologies	-0.75%	-1.25%	-0.85%

In the previous week, Ebang International's average media sentiment score of 1.89 beat TransAct Technologies' score of 1.87 indicating that Ebang International is being referred to more favorably in the media.

Company	Overall Sentiment
Ebang International	Very Positive
TransAct Technologies	Very Positive

Ebang International has a beta of 2.99, indicating that its share price is 199% more volatile than the broader market. Comparatively, TransAct Technologies has a beta of 1.22, indicating that its share price is 22% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ebang International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
TransAct Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

1.2% of Ebang International shares are owned by institutional investors. Comparatively, 74.5% of TransAct Technologies shares are owned by institutional investors. 25.4% of Ebang International shares are owned by insiders. Comparatively, 19.2% of TransAct Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

TransAct Technologies has higher revenue and earnings than Ebang International.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ebang International	$6.54M	2.19	-$14.09M	N/A	N/A
TransAct Technologies	$51.48M	1.02	-$1.24M	-$0.04	N/A

Summary

Ebang International beats TransAct Technologies on 7 of the 11 factors compared between the two stocks.

How does Ebang International compare to Virtuix?

Virtuix (NASDAQ:VTIX) and Ebang International (NASDAQ:EBON) are both small-cap technology companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and media sentiment.

Ebang International has higher revenue and earnings than Virtuix.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Virtuix	$4.25M	9.10	-$16.80M	-$0.70	N/A
Ebang International	$6.54M	2.19	-$14.09M	N/A	N/A

Virtuix presently has a consensus target price of $11.00, suggesting a potential upside of 752.71%. Given Virtuix's stronger consensus rating and higher probable upside, equities research analysts clearly believe Virtuix is more favorable than Ebang International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Virtuix	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Ebang International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Net Margins	Return on Equity	Return on Assets
Virtuix	N/A	N/A	N/A
Ebang International	N/A	N/A	N/A

In the previous week, Virtuix had 1 more articles in the media than Ebang International. MarketBeat recorded 1 mentions for Virtuix and 0 mentions for Ebang International. Ebang International's average media sentiment score of 1.89 beat Virtuix's score of 0.79 indicating that Ebang International is being referred to more favorably in the news media.

Company	Overall Sentiment
Virtuix	Positive
Ebang International	Very Positive

1.2% of Ebang International shares are held by institutional investors. 28.6% of Virtuix shares are held by company insiders. Comparatively, 25.4% of Ebang International shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Virtuix beats Ebang International on 6 of the 10 factors compared between the two stocks.

How does Ebang International compare to Foxx Development?

Ebang International (NASDAQ:EBON) and Foxx Development (NASDAQ:FOXX) are both small-cap technology companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings, valuation and media sentiment.

Foxx Development has higher revenue and earnings than Ebang International.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ebang International	$6.54M	2.19	-$14.09M	N/A	N/A
Foxx Development	$65.92M	0.29	-$9.02M	-$6.87	N/A

In the previous week, Ebang International's average media sentiment score of 1.89 beat Foxx Development's score of 1.87 indicating that Ebang International is being referred to more favorably in the media.

Company	Overall Sentiment
Ebang International	Very Positive
Foxx Development	Very Positive

Ebang International has a net margin of 0.00% compared to Foxx Development's net margin of -79.80%.

Company	Net Margins	Return on Equity	Return on Assets
Ebang International	N/A	N/A	N/A
Foxx Development	-79.80%	N/A	-59.35%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ebang International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Foxx Development	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

1.2% of Ebang International shares are owned by institutional investors. Comparatively, 60.4% of Foxx Development shares are owned by institutional investors. 25.4% of Ebang International shares are owned by company insiders. Comparatively, 31.6% of Foxx Development shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Ebang International has a beta of 2.99, suggesting that its share price is 199% more volatile than the broader market. Comparatively, Foxx Development has a beta of -0.35, suggesting that its share price is 135% less volatile than the broader market.

Summary

Ebang International beats Foxx Development on 5 of the 9 factors compared between the two stocks.

How does Ebang International compare to Mymd Pharmaceuticals?

Ebang International (NASDAQ:EBON) and Mymd Pharmaceuticals (NASDAQ:QCLS) are both small-cap technology companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, media sentiment, risk, profitability, dividends and earnings.

Ebang International's return on equity of 0.00% beat Mymd Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ebang International	N/A	N/A	N/A
Mymd Pharmaceuticals	N/A	-91.64%	-47.48%

1.2% of Ebang International shares are owned by institutional investors. Comparatively, 9.6% of Mymd Pharmaceuticals shares are owned by institutional investors. 25.4% of Ebang International shares are owned by insiders. Comparatively, 0.9% of Mymd Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Ebang International has a beta of 2.99, suggesting that its share price is 199% more volatile than the broader market. Comparatively, Mymd Pharmaceuticals has a beta of 2.09, suggesting that its share price is 109% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ebang International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Mymd Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Mymd Pharmaceuticals has lower revenue, but higher earnings than Ebang International.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ebang International	$6.54M	2.19	-$14.09M	N/A	N/A
Mymd Pharmaceuticals	N/A	N/A	-$11.63M	-$3.48	N/A

In the previous week, Ebang International's average media sentiment score of 1.89 equaled Mymd Pharmaceuticals'average media sentiment score.

Company	Overall Sentiment
Ebang International	Very Positive
Mymd Pharmaceuticals	Very Positive

Summary

Ebang International beats Mymd Pharmaceuticals on 5 of the 7 factors compared between the two stocks.

Get Ebang International News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EBON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EBON vs. The Competition

Export

Metric	Ebang International	Technology Hardware, Storage & Peripherals Industry	Technology Sector	NASDAQ Exchange
Market Cap	$14.14M	$115.37B	$29.70B	$12.83B
Dividend Yield	N/A	1.71%	2.73%	11.79%
P/E Ratio	N/A	28.60	75.29	25.01
Price / Sales	2.19	85.29	587.74	91.06
Price / Cash	N/A	20.14	49.52	52.85
Price / Book	0.06	7.57	9.18	6.03
Net Income	-$14.09M	$3.57B	$677.06M	$348.89M
7 Day Performance	-1.79%	-3.26%	-2.14%	-2.42%
1 Month Performance	11.73%	7.56%	1.89%	2.94%
1 Year Performance	-47.86%	92.12%	184.08%	13.69%

Ebang International Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EBON Ebang International	0.8721 of 5 stars	$2.19 +1.4%	N/A	-48.6%	$14.14M	$6.54M	N/A	260	Positive News Gap Down
ICG Intchains Group	3.1481 of 5 stars	$0.94 -1.1%	$2.50 +166.2%	-47.4%	$57.63M	$31.58M	N/A	133
TACT TransAct Technologies	1.5639 of 5 stars	$5.08 +0.6%	N/A	+14.5%	$52.19M	$51.48M	N/A	120	Positive News
VTIX Virtuix	2.9408 of 5 stars	$1.36 +12.4%	$11.00 +708.8%	N/A	$36.26M	$4.25M	N/A	39	Short Interest Decrease
FOXX Foxx Development	0.577 of 5 stars	$3.00 +4.2%	N/A	-50.9%	$20.24M	$65.92M	N/A	N/A	Positive News Gap Down High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:EBON) was last updated on 9/1/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ebang International (EBON) Competitors

EBON vs. ICG, TACT, VTIX, FOXX, and QCLS

How does Ebang International compare to Intchains Group?

Summary

How does Ebang International compare to TransAct Technologies?

Summary

How does Ebang International compare to Virtuix?

Summary

How does Ebang International compare to Foxx Development?

Summary

How does Ebang International compare to Mymd Pharmaceuticals?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EBON vs. The Competition

Ebang International Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ebang International (EBON) Competitors

EBON vs. ICG, TACT, VTIX, FOXX, and QCLS

How does Ebang International compare to Intchains Group?

Do analysts prefer ICG or EBON?

Do insiders & institutionals have more ownership in ICG or EBON?

Is ICG or EBON more profitable?

Which has more volatility & risk, ICG or EBON?

Does the media refer more to ICG or EBON?

Which has stronger earnings & valuation, ICG or EBON?

Summary

How does Ebang International compare to TransAct Technologies?

Is EBON or TACT more profitable?

Does the media prefer EBON or TACT?

Which has more volatility and risk, EBON or TACT?

Do analysts recommend EBON or TACT?

Do institutionals & insiders believe in EBON or TACT?

Which has stronger earnings & valuation, EBON or TACT?

Summary

How does Ebang International compare to Virtuix?

Which has preferable earnings & valuation, VTIX or EBON?

Do analysts recommend VTIX or EBON?

Is VTIX or EBON more profitable?

Does the media prefer VTIX or EBON?

Do institutionals and insiders hold more shares of VTIX or EBON?

Summary

How does Ebang International compare to Foxx Development?

Which has stronger earnings and valuation, EBON or FOXX?

Does the media prefer EBON or FOXX?

Is EBON or FOXX more profitable?

Do analysts rate EBON or FOXX?

Do insiders and institutionals have more ownership in EBON or FOXX?

Which has more risk and volatility, EBON or FOXX?

Summary

How does Ebang International compare to Mymd Pharmaceuticals?

Is EBON or QCLS more profitable?

Do insiders & institutionals have more ownership in EBON or QCLS?

Which has more volatility and risk, EBON or QCLS?

Do analysts rate EBON or QCLS?

Which has higher valuation and earnings, EBON or QCLS?

Does the media prefer EBON or QCLS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EBON vs. The Competition

Ebang International Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools